Sumo paralogs: Redundancy and divergencies

Frontiers in Bioscience - Scholar

Volumn 5 S, Issue 2, 2013, Pages 544-553

  Citro, Simona ^a   Chiocca, Susanna ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Desumoylases; E3 ligases; Paralog specificity; Review; SIMs; SUMO1; SUMO2 3; SUMO4

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HISTONE DEACETYLASE 4; RECQ HELICASE; RING FINGER PROTEIN; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO 4 PROTEIN; SUMO PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOM SYNDROME; CELL CYCLE G1 PHASE; CELL DESTRUCTION; CELL FUNCTION; CELL NUCLEUS MEMBRANE; CONJUGATION; ENZYME SPECIFICITY; HAPLOINSUFFICIENCY; HEAT SHOCK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MUTAGENESIS; NUCLEAR IMPORT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR PORE; NUCLEAR PORE COMPLEX; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PARALOGY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RING FINGER MOTIF; SINGLE NUCLEOTIDE POLYMORPHISM; STATIC ELECTRICITY; SUMOYLATION; UBIQUITINATION;

EID: 84884333239     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s388     Document Type: Article

References (84)

1. P. Bayer, A. Arndt, S. Metzger, R. Mahajan, F. Melchior, R. Jaenicke and J. Becker: Structure determination of the small ubiquitin-related modifier SUMO-1. J Mol Biol, 280(2), 275-86 (1998)
2. E. Mossessova and C. D. Lima: Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol Cell, 5(5), 865-76 (2000)
3. V. Bernier-Villamor, D. A. Sampson, M. J. Matunis and C. D. Lima: Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin conjugating enzyme Ubc9 and RanGAP1. Cell, 108(3), 345-56 (2002)
4. M. S. Rodriguez, C. Dargemont and R. T. Hay: SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem, 276(16), 12654-9 (2001)
5. K. M. Bohren, V. Nadkarni, J. H. Song, K. H. Gabbay and D. Owerbach: A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem, 279(26), 27233-8 (2004)
6. W. C. Huang, T. P. Ko, S. S. Li and A. H. Wang: Crystal structures of the human SUMO-2 protein at 1.6 A and 1.2 A resolution: implication on the functional differences of SUMO proteins. Eur J Biochem, 271(20), 4114-22 (2004)
7. D. Owerbach, E. M. McKay, E. T. Yeh, K. H. Gabbay and K. M. Bohren: A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem Biophys Res Commun, 337(2), 517-20 (2005)
8. P. G. Pedrioli, B. Raught, X. D. Zhang, R. Rogers, J. Aitchison, M. Matunis and R. Aebersold: Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat Methods, 3(7), 533-9 (2006)
9. M. H. Tatham, E. Jaffray, O. A. Vaughan, J. M. Desterro, C. H. Botting, J. H. Naismith and R. T. Hay: Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem, 276(38), 35368-74 (2001)
10. I. Matic, M. van Hagen, J. Schimmel, B. Macek, S. C. Ogg, M. H. Tatham, R. T. Hay, A. I. Lamond, M. Mann and A. C. Vertegaal: In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol Cell Proteomics, 7(1), 132-44 (2008)
11. H. A. Blomster, S. Y. Imanishi, J. Siimes, J. Kastu, N. A. Morrice, J. E. Eriksson and L. Sistonen: In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification. J Biol Chem, 285(25), 19324-9 (2010)
12. F. Galisson, L. Mahrouche, M. Courcelles, E. Bonneil, S. Meloche, M. K. Chelbi-Alix and P. Thibault: A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Molecular & cellular proteomics: MCP, 10(2), M110 004796 (2011)
13. M. N. Boddy, K. Howe, L. D. Etkin, E. Solomon and P. S. Freemont: PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene, 13(5), 971-82 (1996)
14. M. J. Matunis, E. Coutavas and G. Blobel: A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol, 135(6 Pt 1), 1457-70 (1996)
15. R. Mahajan, C. Delphin, T. Guan, L. Gerace and F. Melchior: A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell, 88(1), 97-107 (1997)
16. F. Ayaydin and M. Dasso: Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell, 15(12), 5208-18 (2004)
17. S. Sachdev, L. Bruhn, H. Sieber, A. Pichler, F. Melchior and R. Grosschedl: PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes & development, 15(23), 3088-103 (2001)
18. A. Pichler, P. Knipscheer, H. Saitoh, T. K. Sixma and F. Melchior: The RanBP2 SUMO E3 ligase is neither HECT-nor RING-type. Nat Struct Mol Biol, 11(10), 984-91 (2004)
19. D. Reverter and C. D. Lima: Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature, 435(7042), 687-92 (2005)
20. M. H. Kagey, T. A. Melhuish and D. Wotton: The polycomb protein Pc2 is a SUMO E3. Cell, 113(1), 127-37 (2003)
21. X. Zhao, T. Sternsdorf, T. A. Bolger, R. M. Evans and T. P. Yao: Regulation of MEF2 by histone deacetylase 4-and SIRT1 deacetylase-mediated lysine modifications. Mol Cell Biol, 25(19), 8456-64 (2005)
22. S. Weger, E. Hammer and R. Heilbronn: Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Lett, 579(22), 5007-12 (2005)
23. S. Subramaniam, K. M. Sixt, R. Barrow and S. H. Snyder: Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science, 324(5932), 1327-30 (2009)
24. Y. Chu and X. Yang: SUMO E3 ligase activity of TRIM proteins. Oncogene, 30(9), 1108-16 (2011)
25. E. J. Shin, H. M. Shin, E. Nam, W. S. Kim, J. H. Kim, B. H. Oh and Y. Yun: DeSUMOylating isopeptidase: a second class of SUMO protease. EMBO Rep (2012)
26. H. Saitoh and J. Hinchey: Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem, 275(9), 6252-8 (2000)
27. Y. Azuma, A. Arnaoutov and M. Dasso: SUMO-2/3 regulates topoisomerase II in mitosis. J Cell Biol, 163(3), 477-487 (2003)
28. T. Sternsdorf, E. Puccetti, K. Jensen, D. Hoelzer, H. Will, O. G. Ottmann and M. Ruthardt: PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Mol Cell Biol, 19(7), 5170-8 (1999)
29. T. Kamitani, H. P. Nguyen, K. Kito, T. Fukuda-Kamitani and E. T. Yeh: Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J Biol Chem, 273(6), 3117-20 (1998)
30. G. Rosas-Acosta, W. K. Russell, A. Deyrieux, D. H. Russell and V. G. Wilson: A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol Cell Proteomics, 4(1), 56-72 (2005)
31. A. C. Vertegaal, J. S. Andersen, S. C. Ogg, R. T. Hay, M. Mann and A. I. Lamond: Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics, 5(12), 2298-310 (2006)
32. D. A. Sampson, M. Wang and M. J. Matunis: The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem, 276(24), 21664-9 (2001)
33. J. Song, Z. Zhang, W. Hu and Y. Chen: Small ubiquitinlike modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J Biol Chem, 280(48), 40122-9 (2005)
34. A. Minty, X. Dumont, M. Kaghad and D. Caput: Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem, 275(46), 36316-23 (2000)
35. J. Song, L. K. Durrin, T. A. Wilkinson, T. G. Krontiris and Y. Chen: Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci U S A, 101(40), 14373-8 (2004)
36. L. Hicke, H. L. Schubert and C. P. Hill: Ubiquitin-binding domains. Nat Rev Mol Cell Biol, 6(8), 610-21 (2005)
37. C. M. Hecker, M. Rabiller, K. Haglund, P. Bayer and I. Dikic: Specification of SUMO1-and SUMO2-interacting motifs. J Biol Chem, 281(23), 16117-27 (2006)
38. O. Kerscher: SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep, 8(6), 550-5 (2007)
39. P. Stehmeier and S. Muller: Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. Mol Cell, 33(3), 400-9 (2009)
40. A. T. Namanja, Y. J. Li, Y. Su, S. Wong, J. Lu, L. T. Colson, C. Wu, S. S. Li and Y. Chen: Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysis. J Biol Chem, 287(5), 3231-40 (2012)
41. D. Y. Lin, Y. S. Huang, J. C. Jeng, H. Y. Kuo, C. C. Chang, T. T. Chao, C. C. Ho, Y. C. Chen, T. P. Lin, H. I. Fang, C. C. Hung, C. S. Suen, M. J. Hwang, K. S. Chang, G. G. Maul and H. M. Shih: Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell, 24(3), 341-54 (2006)
42. C. C. Chang, M. T. Naik, Y. S. Huang, J. C. Jeng, P. H. Liao, H. Y. Kuo, C. C. Ho, Y. L. Hsieh, C. H. Lin, N. J. Huang, N. M. Naik, C. C. Kung, S. Y. Lin, R. H. Chen, K. S. Chang, T. H. Huang and H. M. Shih: Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation. Mol Cell, 42(1), 62-74 (2011)
43. E. Meulmeester, M. Kunze, H. H. Hsiao, H. Urlaub and F. Melchior: Mechanism and consequences for paralogspecific sumoylation of ubiquitin-specific protease 25. Mol Cell, 30(5), 610-9 (2008)
44. Y. Uchimura, T. Ichimura, J. Uwada, T. Tachibana, S. Sugahara, M. Nakao and H. Saitoh: Involvement of SUMO modification in MBD1-and MCAF1-mediated heterochromatin formation. J Biol Chem, 281(32), 23180-90 (2006)
45. N. Sekiyama, T. Ikegami, T. Yamane, M. Ikeguchi, Y. Uchimura, D. Baba, M. Ariyoshi, H. Tochio, H. Saitoh and M. Shirakawa: Structure of the small ubiquitin-like modifier (SUMO)-interacting motif of MBD1-containing chromatin-associated factor 1 bound to SUMO-3. J Biol Chem, 283(51), 35966-75 (2008)
46. J. Zhu, S. Zhu, C. M. Guzzo, N. A. Ellis, K. S. Sung, C. Y. Choi and M. J. Matunis: Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification. J Biol Chem, 283(43), 29405-15 (2008)
47. M. H. Tatham, S. Kim, E. Jaffray, J. Song, Y. Chen and R. T. Hay: Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat Struct Mol Biol, 12(1), 67-74 (2005)
48. J. R. Gareau, D. Reverter and C. D. Lima: Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2. J Biol Chem, 287(7), 4740-51 (2012
49. P. C. Chang, Y. Izumiya, C. Y. Wu, L. D. Fitzgerald, M. Campbell, T. J. Ellison, K. S. Lam, P. A. Luciw and H. J. Kung: Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific. J Biol Chem, 285(8), 5266-73 (2010)
50. S. Zhu, J. Goeres, K. M. Sixt, M. Bekes, X. D. Zhang, G. S. Salvesen and M. J. Matunis: Protection from isopeptidase-mediated deconjugation regulates paralogselective sumoylation of RanGAP1. Mol Cell, 33(5), 570-80 (2009)
51. N. Kolli, J. Mikolajczyk, M. Drag, D. Mukhopadhyay, N. Moffatt, M. Dasso, G. Salvesen and K. D. Wilkinson: Distribution and paralogue specificity of mammalian deSUMOylating enzymes. Biochem J, 430(2), 335-44 (2010)
52. C. D. Lima and D. Reverter: Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J Biol Chem, 283(46), 32045-55 (2008)
53. E. Evdokimov, P. Sharma, S. J. Lockett, M. Lualdi and M. R. Kuehn: Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. J Cell Sci, 121(Pt 24), 4106-13 (2008)
54. F. P. Zhang, L. Mikkonen, J. Toppari, J. J. Palvimo, I. Thesleff and O. A. Janne: Sumo-1 function is dispensable in normal mouse development. Mol Cell Biol, 28(17), 5381-90 (2008)
55. T. Kamitani, K. Kito, H. P. Nguyen, T. Fukuda-Kamitani and E. T. Yeh: Characterization of a second member of the sentrin family of ubiquitin-like proteins. J Biol Chem, 273(18), 11349-53 (1998)
56. F. S. Alkuraya, I. Saadi, J. J. Lund, A. Turbe-Doan, C. C. Morton and R. L. Maas: SUMO1 haploinsufficiency leads to cleft lip and palate. Science, 313(5794), 1751 (2006)
57. M. J. Matunis, J. Wu and G. Blobel: SUMO-1 modification and its role in targeting the Ran GTPaseactivating protein, RanGAP1, to the nuclear pore complex. J Cell Biol, 140(3), 499-509 (1998)
58. R. Mahajan, L. Gerace and F. Melchior: Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J Cell Biol, 140(2), 259-70 (1998)
59. S. Muller, M. J. Matunis and A. Dejean: Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. Embo J, 17(1), 61-70 (1998)
60. S. Ross, J. L. Best, L. I. Zon and G. Gill: SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol Cell, 10(4), 831-42 (2002)
61. Y. Hong, R. Rogers, M. J. Matunis, C. N. Mayhew, M. L. Goodson, O. K. Park-Sarge and K. D. Sarge: Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J Biol Chem, 276(43), 40263-7 (2001)
62. S. R. Chakrabarti, R. Sood, S. Nandi and G. Nucifora: Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. Proc Natl Acad Sci U S A, 97(24), 13281-5 (2000)
63. E. Duprez, A. J. Saurin, J. M. Desterro, V. Lallemand-Breitenbach, K. Howe, M. N. Boddy, E. Solomon, H. de The, R. T. Hay and P. S. Freemont: SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci, 112 ( Pt 3), 381-93 (1999)
64. T. Sternsdorf, K. Jensen, B. Reich and H. Will: The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J Biol Chem, 274(18), 12555-66 (1999)
65. F. Golebiowski, I. Matic, M. H. Tatham, C. Cole, Y. Yin, A. Nakamura, J. Cox, G. J. Barton, M. Mann and R. T. Hay: System-wide changes to SUMO modifications in response to heat shock. Sci Signal, 2(72), ra24 (2009)
66. M. H. Tatham, I. Matic, M. Mann and R. T. Hay: Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci Signal, 4(178), rs4 (2011)
67. M. Castoralova, D. Brezinova, M. Sveda, J. Lipov, T. Ruml and Z. Knejzlik: SUMO-2/3 conjugates accumulating under heat shock or MG132 treatment result largely from new protein synthesis. Biochim Biophys Acta, 1823(4), 911-9 (2012)
68. J. Prudden, S. Pebernard, G. Raffa, D. A. Slavin, J. J. Perry, J. A. Tainer, C. H. McGowan and M. N. Boddy: SUMO-targeted ubiquitin ligases in genome stability. Embo J, 26(18), 4089-101 (2007)
69. Y. Xie, O. Kerscher, M. B. Kroetz, H. F. McConchie, P. Sung and M. Hochstrasser: The yeast Hex3.Slx8 heterodimer is a ubiquitin ligase stimulated by substrate sumoylation. J Biol Chem, 282(47), 34176-84 (2007)
70. K. Uzunova, K. Gottsche, M. Miteva, S. R. Weisshaar, C. Glanemann, M. Schnellhardt, M. Niessen, H. Scheel, K. Hofmann, E. S. Johnson, G. J. Praefcke and R. J. Dohmen: Ubiquitin-dependent proteolytic control of SUMO conjugates. J Biol Chem (2007)
71. H. Sun, J. D. Leverson and T. Hunter: Conserved function of RNF4 family proteins in eukaryotes: Targeting a ubiquitin ligase to SUMOylated proteins. Embo J, 26(18), 4102-12 (2007)
72. J. R. Mullen and S. J. Brill: Activation of the Slx5-Slx8 ubiquitin ligase by poly-small ubiquitin-like modifier conjugates. J Biol Chem, 283(29), 19912-21 (2008)
73. S. Nagai, K. Dubrana, M. Tsai-Pflugfelder, M. B. Davidson, T. M. Roberts, G. W. Brown, E. Varela, F. Hediger, S. M. Gasser and N. J. Krogan: Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent ubiquitin ligase. Science, 322(5901), 597-602 (2008)
74. Z. Wang and G. Prelich: Quality control of a transcriptional regulator by SUMO-targeted degradation. Mol Cell Biol, 29(7), 1694-706 (2009)
75. M. H. Tatham, M. C. Geoffroy, L. Shen, A. Plechanovova, N. Hattersley, E. G. Jaffray, J. J. Palvimo and R. T. Hay: RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol, 10(5), 538-46 (2008)
76. N. Martin, K. Schwamborn, V. Schreiber, A. Werner, C. Guillier, X. D. Zhang, O. Bischof, J. S. Seeler and A. Dejean: PARP-1 transcriptional activity is regulated by sumoylation upon heat shock. Embo J, 28(22), 3534-48 (2009)
77. M. van Hagen, R. M. Overmeer, S. S. Abolvardi and A. C. Vertegaal: RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha. Nucleic Acids Res, 38(6), 1922-31 (2010)
78. R. Bruderer, M. H. Tatham, A. Plechanovova, I. Matic, A. K. Garg and R. T. Hay: Purification and identification of endogenous polySUMO conjugates. EMBO Rep, 12(2), 142-8 (2011)
79. M. Aribi: Candidate genes implicated in type 1 diabetes susceptibility. Curr Diabetes Rev, 4(2), 110-21 (2008)
80. C. Y. Wang and J. X. She: SUMO4 and its role in type 1 diabetes pathogenesis. Diabetes Metab Res Rev, 24(2), 93-102 (2008)
81. D. Guo, M. Li, Y. Zhang, P. Yang, S. Eckenrode, D. Hopkins, W. Zheng, S. Purohit, R. H. Podolsky, A. Muir, J. Wang, Z. Dong, T. Brusko, M. Atkinson, P. Pozzilli, A. Zeidler, L. J. Raffel, C. O. Jacob, Y. Park, M. Serrano-Rios, M. T. Larrad, Z. Zhang, H. J. Garchon, J. F. Bach, J. I. Rotter, J. X. She and C. Y. Wang: A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet, 36(8), 837-41 (2004)
82. T. Sternsdorf, K. Jensen and H. Will: Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol, 139(7), 1621-34 (1997)
83. A. M. Mabb, S. M. Wuerzberger-Davis and S. Miyamoto: PIASy mediates NEMO sumoylation and NFkappaB activation in response to genotoxic stress. Nat Cell Biol, 8(9), 986-93 (2006)
84. R. Boggio and S. Chiocca: Viruses and sumoylation: recent highlights. Curr Opin Microbiol, 9(4), 430-6 (2006)